Sign In
Buy PRVCF
$0.0090
+0 (+0%)
At Close: Jun 03, 2026
PreveCeutical Announces Extension of Non-Brokered Private Placement
07:36pm, Tuesday, 19'th May 2026
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, furt
PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
05:02pm, Tuesday, 12'th May 2026
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, furt
PreveCeutical Announces Non-Brokered Private Placement
03:00am, Wednesday, 22'nd Apr 2026
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV
PreveCeutical Adopts Semi-Annual Financial Reporting
04:00pm, Wednesday, 01'st Apr 2026
Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected to r
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
03:00am, Monday, 30'th Mar 2026
Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical" or the "Company"), a health sciences company that de
BioGene Therapeutics Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
03:00am, Thursday, 12'th Mar 2026
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H0) ("PreveCeutical"), a health sciences company that develops innovative
PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology
03:00am, Wednesday, 25'th Feb 2026
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that t
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents
03:00am, Monday, 09'th Feb 2026
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it has
PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology
07:00am, Thursday, 04'th Dec 2025
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical")
PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
07:00am, Wednesday, 26'th Nov 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - PreveCeutical Medical Inc. (CSE: P
CSE Bulletin: Notice of Distribution and Reclassification - PreveCeutical Medical Inc. (PREV)
03:19pm, Monday, 24'th Nov 2025
Toronto, Ontario--(Newsfile Corp. - Le 24 novembre/November 2025) - PreveCeutical Medical Inc. ("PreveCeutical") has announced the effective date of the reclassification as well as the previously ann
PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.
12:26pm, Thursday, 20'th Nov 2025
Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to it
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
07:00am, Thursday, 20'th Nov 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE: P
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
07:00am, Thursday, 30'th Oct 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia--(Newsfile Corp. - October 30, 2025) - PreveCeutical Medical Inc. (CSE: PR
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
07:00am, Monday, 20'th Oct 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - PreveCeutical Medical Inc. (CSE: P
